Naseem Zojwalla - Jan 25, 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Jan 25, 2024
Transactions value $
$140,400
Form type
4
Date filed
1/29/2024, 07:30 AM
Previous filing
Dec 12, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Options Exercise $140K +20K +42.86% $7.02 66.7K Jan 25, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Options Exercise $0 -20K -8.55% $0.00 214K Jan 25, 2024 Common Stock 20K $7.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on January 31, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.